Currently, there are 2.80B common shares owned by the public and among those 2.79B shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -0.28% and 4.26% over the past three months. JPM shares are trading 8.72% year to date (YTD), with the 12-month market performance up to 41.35% higher. It has a 12-month low price of $179.20 and touched a high of $280.25 over the same period. JPM has an average intraday trading volume of 9.07 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.19%, 1.27%, and 15.26% respectively.
Institutional ownership of JPMorgan Chase & Co (NYSE: JPM) shares accounts for 74.24% of the company’s 2.80B shares outstanding.
It has a market capitalization of $728.72B and a beta (3y monthly) value of 1.09. The stock’s trailing 12-month PE ratio is 13.20, while the earnings-per-share (ttm) stands at $19.75. The company has a PEG of 2.18 and the debt-to-equity ratio at 2.28. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.72% over the week and 2.11% over the month.
Earnings per share for the fiscal year are expected to increase by 2.29%, and 7.62% over the next financial year. EPS should shrink at an annualized rate of 6.06% over the next five years, compared to 12.99% over the past 5-year period.
Looking at the support for the JPM, a number of firms have released research notes about the stock. Wolfe Research stated their Outperform rating for the stock in a research note on January 03, 2025, with the firm’s price target at $269. Robert W. Baird was of a view on November 07, 2024 that the stock is Underperform, while Morgan Stanley gave the stock Equal-Weight rating on September 30, 2024, issuing a price target of $220- $224. Deutsche Bank on their part issued Hold rating on September 03, 2024.
